基于CT的人体成分体积分析在头颈癌患者中的预后价值:可行性研究
结果显示,治疗前颈部骨骼肌体积减少与较差的总生存期相关,治疗前后低脂肪比例也与较差的总生存期相关;多因素分析中,治疗后脂肪衰减增加对总生存期和无复发生存期的预后价值最大。结论认为基于CT的人体成分分析有潜力用于头颈癌患者的风险评估。
要点
- 治疗前颈部骨骼肌体积减少与较差的总生存期独立相关。
- 治疗前后低脂肪比例均与较差的总生存期相关。
- 治疗后脂肪衰减增加对总生存期和无复发生存期的预后价值最大。
核心结论
- 基于CT的人体成分体积分析有潜力用于头颈癌患者的风险评估。
研究设计与样本
- 评估基于体重的变量以及治疗前和治疗后基于CT的人体成分变量。
- 采用Cox比例风险分析评估总生存期和无复发生存期。
主要发现
- 治疗前颈部骨骼肌体积减少与较差的总生存期相关(HR=3.1;95%CI=1.2-7.8;P=.016)。
- 治疗前和治疗后低脂肪比例与较差的总生存期相关(HR=2.5-3.5;95%CI=1.3-9.3;P=.013-.026)。
- 多因素Cox分析中,治疗后脂肪衰减增加对总生存期(HR=4.7;95%CI=2.2-10.3;P<.001)和无复发生存期(HR=4.3;95%CI=2.0-9.5;P<.001)的预后价值最大。
临床怎么用
- 可考虑利用放疗前和治疗后CT图像进行人体成分分析,辅助头颈癌患者风险分层。
局限性
- 单中心回顾性研究,样本量有限(79例),结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to evaluate whether computed tomography (CT)-based volumetric body composition analysis has prognostic value in head and neck cancer (HNC) patients. METHODS: This single-center retrospective study included 79 patients with HNC treated with definitive radiotherapy from March 2009 to December 2018. The patients were assessed for (a) weight-based variables and (b) pretreatment and posttreatment CT-based body composition variables. Overall survival (OS) and recurrence-free survival (RFS) analyses were conducted using Cox proportional hazards analyses. RESULTS: Depletion of cervical skeletal muscle volume on presentation was associated with poor OS (hazard ratio [HR] = 3.1; 95% CI = 1.2-7.8; P = .016). Low fat proportions before and after treatment were associated with poor OS (HR = 2.5-3.5; 95% CI = 1.3-9.3; P = .013-.026). In multivariate Cox analysis, increased posttreatment fat attenuation demonstrated the greatest prognostic value for both OS (HR = 4.7; 95% CI = 2.2-10.3; P < .001) and RFS (HR = 4.3; 95% CI = 2.0-9.5; P < .001). CONCLUSIONS: CT-based body composition analysis has the potential for risk assessment in patients with HNC.
引用
- Choi Y, Ahn KJ, Jang J, et al. Prognostic value of computed tomography-based volumetric body composition analysis in patients with head and neck cancer: Feasibility study. Head Neck. 2020. PMID: 32543090. doi:10.1002/hed.26310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。